Skip to content

Individualized Nutrition Intervention in Children With Cerebral Palsy

The Effect of Individualized Nutrition Intervention on Nutritional Status, Gastrointestinal Symptoms, and Quality of Life in Children With Cerebral Palsy: A Randomized Controlled Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07644572
Acronym
CP-NUTRI
Enrollment
50
Registered
2026-06-12
Start date
2026-05-01
Completion date
2026-12-31
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Cerebral Palsy (CP)

Keywords

Diet intervention

Brief summary

The goal of this clinical trial is to learn if individualized nutrition support can improve nutrition, gastrointestinal symptoms, and quality of life in children with cerebral palsy. The main questions it aims to answer are: Does individualized nutrition support improve the nutrition status of children with cerebral palsy? Does individualized nutrition support improve gastrointestinal symptoms and quality of life? Researchers will compare children who receive individualized nutrition support with children who receive routine care. Participants will: Be randomly placed into one of two groups Have their nutrition status assessed Have their gastrointestinal symptoms and quality of life assessed Receive individualized nutrition support or continue routine care

Interventions

Participants in the intervention group will receive individualized nutrition counseling and dietary recommendations based on nutritional status, dietary intake, anthropometric measurements, gastrointestinal symptoms, and individual needs. The intervention will include assessment of dietary intake, individualized dietary planning, nutrition education, and follow-up during the 8-week study period. No drug, device, or dietary supplement will be administered as part of the intervention.

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 to 12 years diagnosed with cerebral palsy * Children classified as Gross Motor Function Classification System (GMFCS) levels I to III * Children who are orally fed * Children whose parent or legal guardian provides written informed consent * Children who are able to complete baseline and follow-up assessments

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Change in Cerebral Palsy Quality of Life Questionnaire for Children ScoreBaseline and week-8Quality of life will be assessed using the Cerebral Palsy Quality of Life Questionnaire for Children. Scores range from 0 to 100, with higher scores indicating better quality of life. The change in score from baseline to Week 8 will be compared between the individualized nutrition intervention group and the routine care group.

Secondary

MeasureTime frameDescription
Change in Body Mass Index-for-Age Z-ScoreBaseline and Week 8Body mass index-for-age z-score will be calculated using age- and sex-specific reference standards. The change from baseline to Week 8 will be compared between groups.
Change in Gastrointestinal SymptomsBaseline and Week 8Gastrointestinal symptoms will be assessed using the Gastrointestinal Symptom Rating Scale. The mean score ranges from 1 to 7, with higher scores indicating more severe gastrointestinal symptoms. The change in mean score from baseline to Week 8 will be compared between the individualized nutrition intervention group and the routine care group.
Change in Youth Healthy Eating Index ScoreBaseline and Week 8Dietary quality will be assessed using the Youth Healthy Eating Index. The total score ranges from 0 to 100, with higher scores indicating better dietary quality. The change in total score from baseline to Week 8 will be compared between the individualized nutrition intervention group and the routine care group.

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORNilüfer ACAR TEK, Prof. Dr.

Gazi University

STUDY_CHAIRBülent ELBASAN, Prof. Dr.

Gazi University

PRINCIPAL_INVESTIGATORBeda Büşra ÖZALP ÇOLAK

Gazi University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026